Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-05-13

Clinical Trial Update: Evaluating Once Daily Etravirine in Treatment-Naive Adults With HIV Infection [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating once-daily etravirine in treatment-naive adults with HIV has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Intelence (Etravirine)

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: HIV Infections | Phase 2 | Status: COMPLETED | Results posted: 2015-05-13